Respiratory resources
SPIRIVA® Respimat® (tiotropium) is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year. SPIRIVA Respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).
SPIOLTO® Respimat (tiotropium + olodaterol) is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.
Video
5:11 m
Resources
SPIRIVA Respimat patient booklet for severe asthma
Resources
SPIRIVA Respimat patient booklet for COPD
Resources
SPIOLTO Respimat patient booklet for COPD
Video
Recognising and supporting patients with severe asthma
Video
Tailoring treatments for patients with COPD
Video
How do we select the right inhaler?
Video
Asthma in primary care
Infographic
Maintenance therapy for COPD, reserve ICS for when it's really needed
Infographic
Stepping up from monotherapy to dual therapy in COPD
Infographic
LAMA+LABA first-line in COPD patients
Infographic
The wider benefits of the Respimat inhaler
Infographic
The environmental impact of inhalers
Infographic
Respimat Soft Mist Inhaler - Ability to inhale
PC-GB-110744 V2 June 2025